Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)

Breast Cancer Research and Treatment

Volumn 113, Issue 2, 2009, Pages 293-299

  Holm, Neal T ^a   Abreo, Fleurette ^a   Johnson, Lester W ^b   Li, Benjamin D L ^a   Chu, Quyen D ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Chemokine receptor; CXCR4; Locally advanced breast cancer

Indexed keywords

ANTIESTROGEN; CHEMOKINE RECEPTOR CXCR4; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CHI SQUARE TEST; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HELA CELL; HIGH RISK PATIENT; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; METASTASIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STANDARDIZATION; STUDENT T TEST; TREATMENT OUTCOME; TREATMENT RESPONSE; WESTERN BLOTTING;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; DOXORUBICIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM PROTEINS; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, CXCR4; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 58149232541     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-008-9921-8     Document Type: Article

References (38)

1. GN Hortobagyi 1990 Comprehensive management of locally advanced breast cancer Cancer 66 1387 1391
2. GN Hortobagyi FC Ames AU Buzdar SW Kau MD McNeese D Paulus V Hug FA Holmes MM Romsdahl G Fraschini 1988 Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy Cancer 62 2507 2516
3. B Fisher N Gunduz EA Saffer 1983 Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases Cancer Res 43 1488 1492
4. B Fisher J Bryant N Wolmark E Mamounas A Brown ER Fisher DL Wickerham M Begovic A DeCillis A Robidoux RG Margolese AB Cruz Jr JL Hoehn AW Lees NV Dimitrov HD Bear 1998 Effect of preoperative chemotherapy on the outcome of women. with operable breast cancer J Clin Oncol 16 2672 2685
5. S Goble HD Bear 2003 Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions Surg Clin North Am 83 943 971
6. JC Chang EC Wooten A Tsimelzon SG Hilsenbeck MC Gutierrez R Elledge S Mohsin CK Osborne GC Chamness DC Allred P O'Connell 2003 Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer Lancet 362 362 369
7. SM Scholl JY Pierga B Asselain P Beuzeboc T Dorval E Garcia-Giralt M Jouve T Palangie Y Remvikos JC Durand 1995 Breast tumour response to primary chemotherapy predicts local and distant control as well as survival Eur J Cancer 31A 12 1969 1975
8. VF Semiglazov EE Topuzov JL Bavli VM Moiseyenko OA Ivanova IK Seleznev AA Orlov NY Barash OM Golubeva OF Chepic 1994 Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer Ann Oncol 5 7 591 595
9. A Makris TJ Powles M Dowsett CK Osborne PA Trott IN Fernando SE Ashley MG Ormerod JC Titley RK Gregory DC Allred 1997 Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas Clin Cancer Res 3 4 593 600
10. L Mauriac G MacGrogan A Avril M Durand A Floquet M Debled JM Dilhuydy F Bonichon 1999 Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS) Ann Oncol 10 1 47 52
11. JA van der Hage CJ van de Velde JP Julien M Tubiana-Hulin C Vandervelden L Duchateau 2001 Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 22 4224 4237
12. HM Kuerer LA Newman TL Smith FC Ames KK Hunt K Dhingra RL Theriault G Singh SM Binkley N Sneige TA Buchholz MI Ross MD McNeese AU Buzdar GN Hortobagyi SE Singletary 1999 Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy J Clin Oncol 17 2 460 469
13. JY Pierga E Mouret V Dieras V Laurence P Beuzeboc T Dorval T Palangie M Jouve A Vincent-Salomon S Scholl JM Extra B Asselain P Pouillart 2000 Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer Br J Cancer 83 11 1480 1487
14. DR McCready GN Hortobagyi SW Kau 1989 The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer Arch Surg 124 21 25
15. C Botti P Vici M Lopez 1995 Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast J Am Coll Surg 181 202 208
16. HM Kuerer LA Newman AU Buzdar 1998 Residual metastatic ALNs following neoadjuvant chemotherapy predicts disease-free survival in locally advanced breast cancer patients Am J Surg 176 502 509
17. WG Cance LA Carey BF Calvo 2002 Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival Ann Surg 236 295 303
18. LA Carey R Metzger EC Dees 2005 American Joint Committee on Cancer tumor-node-metastasis stage after neoadjuvant chemotherapy and breast cancer outcome J Natl Cancer Inst 97 1137 1142
19. A Müller B Homey H Soto N Ge 2001 Involvement of chemokine receptors in breast cancer metastasis Nature 410 50 56
20. N Holm K Byrnes B Li R Turnage F Abreo J Mathis QD Chu 2007 Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence J Surg Res 141 53 59
21. B Lee T Lee S Avraham H Avraham 2004 Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1α in breast cancer cell migration through human brain microvascular endothelial cells Mole Cancer Res 2 327 338
22. Z Liang Y Yoon J Votaw 2005 Silencing of CXCR4 blocks breast cancer metastasis Cancer Res 65 967 971
23. N Lapteva A Yang D Sanders 2005 CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo Cancer Gene Ther 12 84 89
24. M Smith K Luker J Garbow 2004 CXCR4 regulates growth of both primary and metastatic breast cancer Cancer Res 64 8604 8612
25. American Joint Committee on Cancer (2002) AJCC Cancer Staging Manual, 6th edn
26. D Tiezzi J Andrade A Ribeiro-Silva F Zola 2007 HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination BMC Cancer 7 36
27. S Singletary M McNeese G Hortobagyi 1992 Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma Cancer 69 2849 2852
28. M Alassas Q Chu G Burton F Ampil 2005 Neoadjuvant chemotherapy in stage III breast cancer Am Surgeon 71 487 492
29. C Isaccs V Stearns DF Hayes 2001 New prognostic factors for breast cancer recurrence Semin Oncol 28 53 67
30. L Gianni M Zambetti K Clark J Baker 2005 Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer J Clin Oncol 23 7265 7277
31. K Hess K Anderson W Symmans V Valero 2006 Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer J Clin Oncol 24 4236 4244
32. T Sørlie C Perou C Fan S Geisler 2006 Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer Mol Cancer Ther 5 2914 2918
33. J Pierga J Reis-Filho S Cleator T Dexter 2007 Microarray-based comparative genomic hybridisation of breast cancer patients receiving neoadjuvant chemotherapy Br J Cancer 96 341 351
34. S Paik S Shak G Tang 2004 A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817 2826
35. T Palangie V Mosseri J Mihura F Campana 1994 Prognostic factors in inflammatory breast cancer and therapeutic implications Eur J Cancer 30A 921 927
36. A Honkoop P van Diest J de Jong 1998 Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer Br J Cancer 77 621 626
37. A Proudfoot 2002 Chemokine receptors: multifaceted therapeutic targets Nat Rev Immunol 2 106 115
38. Y Li Y Pan Y Wei X Cheng 2004 Upregulation of CXCR4 is essential for HER-2 mediated tumor metastasis Cancer Cell 6 459 469